Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* breast cancer~* undergoing unilateral mastectomy with or without axillary node dissection~* received adequate oral and written information about the study and signed an informed-consent form~Exclusion Criteria:~* pregnant or breastfeeding~* known thromboembolic disease or with high risk of thromboembolism, warranting extra anticoagulation in connection with the procedure~* known allergy to tranexamic acid/Cyklokapron®

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- topical tranexamic acid (Type: EXPERIMENTAL): tranexamic acid to be smeared on surgical wounds before closure
- placebo control (Type: PLACEBO_COMPARATOR): saline to be smeared on surgical wounds before closure

Based on this trial design, predict the completion outcome and termination type (if applicable).